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We investigated the role of mouse adenovirus type 1 (MAV-1) early region 1A (E1A) protein in adenovirus respiratory infection. Intranasal
(i.n.) inoculation of mice with wild type (wt) virus induced chemokine and cellular inflammatory responses in the lung. We observed similar
responses in mice infected with an E1A-null mutant virus at the same dose, although the magnitude of these responses was lower. Levels of
viral hexon gene expression were lower in the lung following infection with E1A-null virus than with wt virus. When input doses were
adjusted so that equivalent viral loads were present following infection with varying doses of wt and E1A-null virus, we observed equivalent
chemokine upregulation in the lung. Dissemination to the brain occurred following i.n. inoculation with equal doses of wt or E1A-null virus,
but viral gene expression and viral loads were lower and the magnitude of chemokine responses was lower in brains of E1A-null virus-infected
mice. CD4 and CD8 T cells and neutrophils were recruited to the brains of mice infected with either wt or E1A-null virus. Together, these data
suggest that MAV-1 E1A makes important contributions to viral replication in the lung and the brain following i.n. inoculation. However, E1A
is not essential for the induction of inflammatory responses in the lung or for viral dissemination out of the lung.
© 2006 Elsevier Inc. All rights reserved.Keywords: Adenovirus; Chemokine; Lung; Brain; InflammationIntroduction
Adenoviruses are common causes of respiratory infections,
which can present with a wide range of clinical syndromes
from mild upper respiratory tract infections to more severe
manifestations such as necrotizing pneumonitis, bronchiolitis
obliterans and hyperlucent lung syndrome (reviewed in
Horwitz, 2001). In developing countries, adenoviruses are
associated with severe acute pneumonia in children and are a
major cause of morbidity and mortality (Kajon et al., 2003).⁎ Corresponding author. Fax: +1 734 936 7635.
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doi:10.1016/j.virol.2006.08.013Immunocompromised patients such as bone marrow trans-
plant recipients are at risk for greatly increased morbidity and
mortality from adenovirus infection (Hale et al., 1999; Walls
et al., 2003). Evidence suggests that adenovirus infection
plays a role in the pathogenesis of chronic lung diseases such
as asthma and chronic obstructive lung disease (COPD,
reviewed in Hogg, 2001). Adenoviral DNA is found in
respiratory epithelial cells in patients with COPD (Elliott et
al., 1995; Matsuse et al., 1992), and adenovirus infection
increases cigarette smoke-induced inflammation in the lungs
of guinea pigs (Vitalis et al., 1998). There is growing interest
in solidifying the links between adenovirus infection and
chronic lung disease, both from the standpoint of understand-
ing the pathogenesis of these disorders and developing novel
therapies directed at either the virus or host responses induced
or modulated by the virus.
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been associated with lung inflammation and the induction of
chemokines critical to the inflammatory response (Bonville et
al., 1999; Domachowske et al., 2000; Harrod et al., 1998; Miller
et al., 2004; Miyazato et al., 2000; Tripp et al., 2000; Wareing et
al., 2004; Weinberg et al., 2002). Relatively few studies have
used in vivo animal models to examine chemokine responses to
respiratory infection with human adenovirus (Harrod et al.,
1998; Kajon et al., 2003). In vivo studies of human adenovirus
pathogenesis are limited by the strict species specificities of the
adenoviruses.
Mouse adenovirus type 1 (MAV-1) is an excellent animal
model system for studying adenovirus pathogenesis. The
availability of numerous immunological reagents for mice, as
well as a wide variety of immunocompetent, immunodeficient,
transgenic and knockout mouse strains provides the means to
define viral and host factors involved in both acute and
persistent adenovirus infections. MAV-1 causes both acute and
persistent infection in mice (Smith and Spindler, 1999).
Intraperitoneal (i.p.) inoculation of C57BL/6 mice leads to a
dose-dependent encephalomyelitis (Guida et al., 1995), with
endothelial cell activation and vasculitis in the central nervous
system (Charles et al., 1998; Guida et al., 1995; Kajon et al.,
1998; Spindler et al., 2001). Persistent infection is established
following i.p. inoculation of NIH Swiss outbred mice, with
virus shed in the urine and viral DNA detected in the brain,
spleen, lymph nodes and kidneys for up to 55 weeks post-
infection (Smith et al., 1998). Following i.p. infection, virus can
be detected in multiple organs, including lung, spleen, brain,
kidney and lymph nodes, between 7 and 17 dpi (Kajon et al.,
1998). MAV-1 organ tropism following intranasal (i.n.)
inoculation is identical to that observed following i.p.
inoculation, which is the more commonly used route of
inoculation in MAV-1 studies (Kajon et al., 1998).
The immune response to acute MAV-1 infection is multifac-
eted. Neutralizing antibodies develop by 6 dpi (Moore et al.,
2004). T cells are critical both for the acute immunopathology
observed in MAV-1-induced encephalomyelitis and for long-
term host survival following i.p. infection (Moore et al., 2003).
Mice lacking B cells or Bruton's tyrosine kinase (Btk) are highly
susceptible to acute MAV-1 infection (Moore et al., 2004),
indicating that B cells also play a critical role in MAV-1
pathogenesis. By 4 days post-infection (dpi), increased levels of
cytokine and chemokine transcripts are present in the brains of
C57BL/6 mice infected i.p. (Charles et al., 1999a, 1999b).
Inflammatory responses toMAV-1 respiratory infection have not
been described in as much detail. Following i.n. inoculation
of newborn mice with 2×106 plaque forming units (PFU) of
MAV-1, Gottlieb et al. demonstrated peribronchiolar infiltrates
comprised of macrophages and lymphocytes at 3 dpi (Gottlieb
and Villarreal, 2000), whereas little inflammation was present in
the lungs of adult NIH Swiss outbred mice following i.n.
inoculation of 103 PFU (Kajon et al., 1998). Using i.n.
inoculation of adult mice with 105 PFU, we demonstrated
MAV-1 protein in respiratory epithelial cells, persistence of viral
DNA in the lungs up to 21 dpi and chemokine upregulation in the
lung between 7 and 14 dpi (Weinberg et al., 2005).Adenovirus early region 1A (E1A) proteins are transcrip-
tional regulators of gene expression. E1A proteins exert their
control on gene expression by interacting with cellular proteins
through three conserved domains, conserved region (CR)1, CR2
and CR3. These interactions may influence cellular inflamma-
tory responses via the activation of transcription factors such as
NF-κB (Schmitz et al., 1996) and activating protein (AP)-1
(Kleinberger and Shenk, 1993; Muller et al., 1989). Clinical and
experimental animal data have provided the basis for postulating
that the human adenovirus E1A protein is responsible for
immunomodulatory effects contributing to chronic lung diseases
(reviewed in Hogg, 2001). MAV-1 early region 1 encodes three
overlapping mRNAs, one of which corresponds to the human
adenovirus E1A 289 aa protein and encodes a 200 aa protein
(Ball et al., 1989). The MAV-1 E1A protein sequence has
approximately 40% sequence similarity compared to the human
adenovirus E1A 289 aa protein in CR1, CR2 and CR3 (Ball et
al., 1989). MAV-1 E1A shares functional roles with human
adenovirus E1A, for example, binding to the mouse cellular
proteins retinoblastoma protein (pRb), pRb-related proteins p107
and p130, and Sur2 (Fang and Spindler, 2005; Fang et al., 2004;
Smith et al., 1996) and transactivating the human adenovirus type
5 E3 promoter (Ball et al., 1988). The MAV-1 model is
therefore well suited to use in the study of adenovirus E1A-
mediated effects on pulmonary pathophysiology.
As regulators of both viral and cellular gene transcription,
adenovirus E1A proteins likely make major contributions to
viral pathogenesis. In this study, we used i.n. infection of
C57BL/6 mice with an E1A-null mutant MAV-1 to assess the
role of MAV-1 E1A in both the induction of inflammatory
responses in the lung and brain and the dissemination of virus to
the brain following acute respiratory infection. We demonstrate
that E1A-null virus induces less inflammation in the lungs and
brain than wt virus, most likely due to a replication defect rather
than an absence of direct MAV-1 E1A effects on host
inflammatory responses. Furthermore, although viral gene
expression and viral loads were lower in brains of E1A-null
virus-infected mice, we show that MAV-1 E1A is not essential
for the spread of virus from lung to brain following i.n.
inoculation. Thus, the effects of MAV-1 E1A on acute
inflammatory responses and dissemination from the lung to
the brain are most likely indirect, via contributions of E1A to
MAV-1 replication.
Results
Lung chemokine responses to acute respiratory infection
To determine the contributions of MAV-1 E1A to lung
inflammatory responses elicited by MAV-1, we used ribonu-
clease protection assay (RPA) to quantify chemokine responses
in the lungs of mock-infected mice or mice infected i.n. with
either wt MAV-1 or the E1A-null mutant, pmE109. As we have
previously demonstrated (Weinberg et al., 2005), there was
minimal upregulation of chemokine gene expression prior to
7 dpi in the lungs of any mice (Fig. 1B). Infection with 105 PFU
wt MAV-1, but not mock infection, upregulated the expression
Fig. 1. Chemokine responses to respiratory infection. Chemokine gene expression and protein production were measured in the lungs of mice infected i.n. with 105
PFU of wt MAV-1 or pmE109. Animals mock-infected with conditioned media were included as controls. (A) Representative assay demonstrating detection by RPA of
chemokine gene expression in the lungs of infected mice at 7 dpi. Each lane represents data obtained from a separate mouse. (B) Kinetics of chemokine gene
expression in the lung for representative chemokine genes over the course of acute lung infection. Quantified PhosphorImager data are presented as percentages of the
expression of the L32 housekeeping gene. Mean values and standard deviations are presented for between 3 and 7 mice per group at each time point. Statistical
significance between groups was determined using ANOVA with subsequent Newman–Keuls analysis between pairs where appropriate (*P<0.05 and **P<0.01
compared to mock-infected mice; †P<0.05 and ††P<0.01 compared to pmE109-infected mice). (C) ELISA measurement of protein levels of representative
chemokines in the lungs of infected mice. P values represent statistical significances between groups determined using ANOVA with subsequent Newman–Keuls
analysis between pairs where appropriate.
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true for both the CXC chemokines (MIP-2 and IP-10) and the
CC chemokines (RANTES, MIP-1α, MIP-1β, MCP-1, TCA-3,
eotaxin) that were measured. By 15 dpi, levels of expression of
chemokine genes had decreased in the lungs of mice infected
with wt MAV-1 but remained elevated compared to levels
measured in mock-infected mice (Fig. 1B and data not shown).
Infection with the same dose (105 PFU) of pmE109 also
upregulated chemokine gene expression in the lung. Similar to
infection with wt MAV-1, chemokine responses to pmE109
infection were first detected at 7 dpi (Fig. 1A and B). Levels of
chemokine gene expression had decreased by 15 dpi for the
majority of chemokines measured, although levels of MCP-1
expression remained stable at 15 dpi following infection with
pmE109 (Fig. 1B). The overall kinetics of chemokine
upregulation were similar in the lungs of mice infected with
wt virus or pmE109, though the magnitude of the response was
significantly lower following infection with pmE109 at both 7
and 15 dpi.We used ELISA to verify that changes in chemokine gene
expression following i.n. infection with wt virus or pmE109
were reflected in corresponding changes in chemokine protein
production. Levels of two representative chemokines, RANTES
and MCP-1, were measured in lung homogenates at 7 dpi, the
peak of chemokine upregulation as measured by RPA. In both
cases, levels of chemokine protein were significantly greater in
the lungs of mice infected with wt virus than in mice infected
with pmE109. Levels of RANTES and MCP-1 protein were
greater in the lungs of mice infected with pmE109 than in
mock-infected mice, but these differences were not statistically
significant (Fig. 1C).
Lung cellular inflammatory responses to acute respiratory
infection
Chemokines mediate the recruitment of a variety of cell
types involved in the host response to viruses and other
pathogens (Luster, 1998). Because we saw greater chemokine
Fig. 3. Detection of viral gene expression in the lung. Expression of the MAV-1
hexon gene was measured by RPA in the lungs of mice at 7 dpi. (A) Protected
probe fragments for hexon and the L32 housekeeping gene are shown from RNA
isolated from lungs of mock-infected mice and mice infected with 105 PFU of wt
MAV-1 or pmE109. (B) Quantified PhosphorImager data from mice in panel A
are presented as a percentage of L32 expression. Circles represent values for
individual mice, and horizontal bars represent mean values for each group.
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pmE109, we predicted that cellular inflammatory responses in
the lung would also differ. We examined hematoxylin and
eosin-stained sections of lungs harvested at various time points
following infection of mice with wt virus or the E1A-null
mutant (Fig. 2). No inflammatory response was present at any
time point in the lungs of mock-infected mice or earlier than
7 dpi in the lungs of mice infected with either virus (data not
shown). Consistent with data presented in our previous report
(Weinberg et al., 2005), a patchy cellular infiltrate was present
throughout the lungs of mice infected with wt MAV-1 at 7 and
15 dpi (Fig. 2). This cellular infiltrate was predominantly
focused around larger airways in the lung, although scattered
areas of hypercellularity were also present in alveolar walls at
these time points. In contrast, lungs of mice infected with
pmE109 at 7 dpi more closely resembled the lungs of mock-
infected mice, with a relative paucity of cellular inflammation.
By 15 dpi, an increased but still comparatively mild infiltrate
was present in the lungs of pmE109-infected mice. Again, this
infiltrate tended to be focused around larger airways, although
scattered areas of hypercellularity were also present in other
areas of the lung (Fig. 2, inset). Thus, the intensity of cellular
inflammatory responses in the lung correlated with chemokine
upregulation induced by wt MAV-1 or pmE109 infection, but
the responses were not qualitatively different in wt virus- and
pmE109-infected mice.
Detection of virus in the lung
To verify the presence of virus in infected mice, we harvested
total RNA from lungs of mice at multiple time points and used
RPA to detect expression of the MAV-1 hexon gene. We did not
detect hexon gene expression at any time point in the lungs of
mock-infected mice. Hexon expression was readily detected in
the lungs of mice infected with 105 PFU of wt virus or pmE109Fig. 2. Lung cellular inflammatory responses to respiratory infection. Hematoxylin a
105 PFU of wt MAV-1 or pmE109 at 7 and 15 dpi. Inset at lower right panel represents
bar, 100 μm.at 7 dpi (Fig. 3A) but not at 15 dpi (data not shown). At 7 dpi,
quantified levels of lung hexon gene expression were greater in
mice infected with wt virus than with the E1A-null mutant,
pmE109, although this difference was not statistically different
(Fig. 3B).
Effects of differing inoculum doses on chemokine induction
Because the mean level of hexon gene expression was lower
at 7 dpi in pmE109-infected mice than in wt virus-infectednd eosin-stained sections of lungs of mock-infected mice and mice infected with
a separate field from the same lung of a pmE109-infected mouse at 15 dpi. Scale
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the absence of E1A rather than the absence of a direct effect of
E1A on the induction of inflammatory responses was
responsible for the observed differences in chemokine upregu-
lation in the lung following i.n. infection with wt or mutant
virus. To evaluate this possibility, we conducted an experiment
in which mice were infected with 104 or 105 PFU of wt MAV-1,
or 105 PFU of pmE109. We used RPA to quantify chemokine
gene expression in the lungs of these mice at 7 dpi, the time of
peak chemokine responses in the lung. As in Fig. 1, the
expression of representative chemokine genes was greater in the
lungs of mice infected with 105 PFU of wt virus than in mice
infected with 105 PFU of pmE109 (Fig. 4A). Levels of
chemokine gene expression in the lungs of mice were
correspondingly lower in the lungs of mice infected with 104
PFU than with 105 PFU of wt MAV-1 and were similar to those
measured in the lungs of mice infected with 105 PFU of
pmE109 (Fig. 4A).
To determine whether the absence of E1A resulted in lower
levels of viral genome in the lungs of mice infected withFig. 4. Effects of inoculum doses on chemokine induction and viral load. Mice
were infected i.n. with 104 or 105 PFU of wt MAV-1 or 105 PFU of pmE109 and
evaluated at 7 dpi. (A) Quantified levels of representative chemokine gene
expression in the lungs of infected mice are presented as percentages of L32
expression. Mean values and standard deviations are presented for 3 mice per
group. (B) Quantitative real-time PCR was used to measure copy number of the
MAV-1 hexon gene in DNA extracted from the lungs of the same infected mice.
Circles represent copy numbers in individual mice and horizontal bars represent
arithmetic mean values for each group. P values represent statistical
significances between groups determined using ANOVA with subsequent
Newman–Keuls analysis between pairs where appropriate.pmE109 compared to wt virus when chemokine responses were
similar (Fig. 4A), we used sensitive quantitative real-time PCR
(qPCR) to compare viral genome levels in the lungs of these
mice (Fig. 4B). Primers were designed to amplify a segment of
the MAV-1 hexon gene, which is present in both wt MAV-1 and
pmE109. Viral genomes were detected in the lungs of mice
infected with both 104 and 105 PFU of wt MAV-1 and with 105
PFU of pmE109 (Fig. 4B). The viral load in the lungs following
infection with 105 PFU of pmE109 was lower than that
following 105 PFU of wt MAV-1. As expected, the viral load in
the lung following infection with 104 PFU of MAV-1 was also
lower than that following infection with 105 PFU of wt MAV-1,
and although it was somewhat higher than that following
infection with 105 PFU of pmE109, this difference was not
statistically significant. Together, these data suggest that lower
levels of chemokine upregulation in the lung following
infection with pmE109 occur because less virus is present,
likely due to an in vivo replication defect in the lungs in the
absence of MAV-1 E1A.
In vitro replication of wild type and E1A-deficient MAV-1
To test the possibility that the E1A-null virus replicates less
well than wt virus in mouse lung cells, we analyzed viral gene
expression in two cell lines relevant to a model of pulmonary
inflammation. The MH-S cell line is a mouse alveolar
macrophage cell line (Mbawuike and Herscowitz, 1989), and
the LA-4 cell line is a mouse alveolar epithelial cell-like cell line
(Stoner et al., 1975). We infected monolayers of each cell type
with wt MAV-1 or pmE109 at both low (0.1) and high (5) MOIs
and harvested total RNA from the cells at 48 h post-infection
(hpi). We used RPA to detect hexon gene expression. Quantified
levels of hexon gene expression did not differ between wt virus-
and pmE109-infected MH-S cells at either MOI (Fig. 5A). In
LA-4 cells, levels of hexon gene expression were substantially
greater than in MH-S cells following infection with both viruses
(compare y axis in Figs. 5A to B). Levels of hexon gene
expression in pmE109-infected LA-4 cells were significantly
lower than in wt virus-infected cells at the low MOI of 0.1 (Fig.
5B). Levels of hexon gene expression in pmE109-infected LA-
4 cells were higher compared to wt virus-infected LA-4 cells at
the high MOI of 5. This difference was small but statistically
significant (Fig. 5B). This pattern in LA-4 cells was like that in
NIH 3T6 cells, in which a replication defect was seen following
pmE109 infection at low, but not high, MOIs (Fang and
Spindler, 2005).
Detection of virus in the brain following intranasal infection
The central nervous system (CNS) is one of the principal
targets of MAV-1 infection (Guida et al., 1995; Kring et al.,
1995). MAV-1 produces CNS symptoms (ataxia, hyperreflexia,
hyperesthesia, paresis and flaccid paralysis) following i.p.
inoculation in outbred mice (Kring et al., 1995). MAV-1
localizes to vascular endothelium in the brain following both i.
p. and i.n. inoculation (Charles et al., 1998; Kajon et al., 1998),
and i.p. MAV-1 infection of susceptible mouse strains produces
Fig. 6. Detection of virus in the brain following intranasal infection. Viral gene
expression and viral load were measured in the brains of mice infected i.n. with
105 PFU of wt MAV-1 or pmE109. (A) Expression of the MAV-1 hexon gene
was measured by RPA. Quantified PhosphorImager data are presented as a
percentage of L32 expression. Mean values and standard deviations are
presented for between 4 and 7 mice per group at each time point. (B)
Quantitative real-time PCR was used to measure copy number of the MAV-1
hexon gene in DNA extracted from the brains of infected mice. Squares and
triangles represent copy numbers in individual wt MAV-1-infected and pmE109-
infected mice, respectively. Horizontal bars represent mean values for each
group. P values represent statistical significances between groups determined
using Student's t test.
Fig. 5. In vitro replication of wild type and E1A-null MAV-1. Using RPA, MAV-
1 hexon gene expression was measured in (A) MH-S and (B) LA-4 cells 48 h
following infection with wt MAV-1 or pmE109 at the indicated MOI. Quantified
PhosphorImager data are presented as a percentage of L32 expression. Means
and standard deviations of three replicates per group are presented. Statistical
significance between groups was determined using Student's t test (*P<0.05
and †P<0.01).
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Although the 50% lethal dose of pmE109 is higher than that of
wt MAV-1 following i.p. infection of Swiss outbred mice (Smith
et al., 1998), pmE109 was found in the same organs, including
the brain, as wt MAV-1 following i.p. infection with 104 PFU
(Smith et al., 1998). However, at a lower dose of 1 PFU,
pmE109 did not reach the brain by 14 dpi, whereas wt MAV-1
did (Smith et al., 1998).
We assessed the role of MAV-1 E1A on spread of virus to the
brain in inbred mice following i.n. inoculation with 105 PFU of
wt MAV-1 or pmE109 using RPA to detect hexon gene
expression. Hexon gene expression was not detected by RPA in
RNA extracted from brains at any time point prior to 11 dpi
(data not shown). At 11 dpi, hexon gene expression was
detected in the brains of mice infected with both wt virus and
pmE109 (Fig. 6A), and it was higher in the brains of wt
virus-infected mice. Hexon expression in the brain at 15 dpi was
lower and did not differ between groups (Fig. 6A). Hexon gene
expression was not detectable by RPA in any mice at 22 dpi
(data not shown).
To verify the RPA data in the brain, we used qPCR to
measure viral loads at the same time points. Viral load levels
showed the same pattern as hexon gene expression levels. At
11 dpi, viral genomes were detected in both wt virus-infected
and pmE109-infected mice (Fig. 6B). The viral loads were
significantly higher in the brains of wt virus-infected mice than
in pmE109-infected mice. Brain viral loads were equivalent
between the two groups at 15 dpi. Even though viral gene
expression was not detected by RPA in the brain at 22 dpi, viral
genomes were detected by qPCR at this time point in the brainsof both wt virus-infected and pmE109-infected mice (Fig. 6B).
Viral loads at 22 dpi were greater in the brains of wt virus-
infected mice than in pmE109-infected mice, although this was
not a statistically significant difference.
Brain chemokine responses following intranasal infection
Chemokine responses induced in the brain by acute MAV-1
infection following i.p. inoculation have been described
(Charles et al., 1999a). In that report, upregulated expression
of multiple chemokines was noted over the first 96 h post-
infection in C57BL/6 mice (Charles et al., 1999a). IP-10, MCP-
1 and TCA-3 were the most prominently expressed chemokines
following i.p. inoculation (Charles et al., 1999b). We examined
brain chemokine expression induced by i.n. infection with wt
and E1A-null mutant virus to determine whether E1A
influences brain chemokine responses. We used RPA to detect
chemokine gene expression in total RNA isolated from brains at
multiple time points following infection. Chemokine gene
mRNA expression was not detected in the brains of mock-
infected mice at any time point and was not detected in the
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(data not shown). At 11 dpi, the expression of multiple
chemokine gene mRNAs was upregulated in wt virus-infected
and pmE109-infected mice, although the magnitude of
upregulation was greater in wt virus-infected mice (Fig. 7A).
The kinetics of chemokine mRNA expression for RANTES
and TCA-3, two of the most highly expressed chemokine genes
in the MAV-1-infected brain, are presented in Fig. 7B.
Following the initial upregulation detected at 11 dpi, RANTES
gene mRNA expression remained stably elevated in the brains
of wt virus-infected mice at both 15 and 22 dpi. In the brains of
pmE109-infected mice, levels of RANTES gene expression
increased between 11 and 15 dpi and then remained stable
between 15 and 22 dpi. Throughout this time course, levels of
RANTES gene expression were lower in the brains of pmE109-
infected mice than in wt virus-infected mice. TCA-3 gene
expression was also upregulated at 11 dpi in the brains of mice
infected with wt virus or pmE109 compared to mock-infected
mice, though wt virus infection induced a greater TCA-3
response than did pmE109 (Fig. 7A and B). By 15 dpi, TCA-3
expression had decreased to similar levels in the brains of both
wt virus-infected and pmE109-infected mice, although it
remained above baseline levels measured in mock-infected
mice. TCA-3 expression remained slightly elevated in the brains
of mice from both groups at 22 dpi. At this time point, TCA-3
expression was significantly greater in brains of wt virus-
infected mice than in pmE109-infected mice, although the
difference was relatively small. Expression of other chemokines
measured followed patterns similar to those described for TCA-
3 (data not shown). Interestingly, RANTES was the onlyFig. 7. Brain chemokine responses following intranasal infection. Chemokine gene e
MAV-1 or pmE109. Animals mock-infected with conditioned media were include
Representative assay demonstrating detection by RPA of chemokine gene express
expression in the brain for representative chemokine genes over the course of acu
Quantified PhosphorImager data are presented as percentages of the expression of the
between 4 and 7 mice per group at each time point. Statistical significance between g
between pairs where appropriate (*P<0.01 and †P<0.001).chemokine measured whose expression remained substantially
upregulated up to 22 dpi.
Brain cellular inflammatory responses following intranasal
infection
We have previously shown that T cells play a crucial role in
MAV-1-induced CNS immunopathology following i.p. infec-
tion (Moore et al., 2003). The pattern of chemokine upregula-
tion that we detected in the brains of mice following i.n.
infection with either wt virus or pmE109 suggested that T cells
were also recruited to the brain following i.n. infection. To
verify this possibility, a group of mice were mock-infected or
infected i.n. with 105 PFU of wt virus or pmE109. We assessed
cellular inflammation present in hematoxylin and eosin-stained
sections of brains (Fig. 8). No infiltrate was present in the brains
of mock-infected mice at 11 or 15 dpi. At 11 dpi, a mononuclear
cell infiltrate was observed surrounding scattered small blood
vessels in the brains of wt virus-infected mice. Similar
perivascular cuffing was present in the brains of mice infected
with pmE109, although involved blood vessels were less
common in these animals. Mononuclear cell infiltrates
surrounding blood vessels were also present at 15 dpi in the
brains of mice infected with wt virus or pmE109, but again was
again less common in the brains of pmE109-infected mice
compared to wt virus-infected mice.
We indirectly phenotyped the cells infiltrating the brain using
RPA to quantify the expression of genes encoding the leukocyte
cell surface markers CD4 and CD8 (T cells), CD19 (B cells) and
F4/80 (macrophages). Expression levels of genes encodingxpression was measured in the brains of mice infected i.n. with 105 PFU of wt
d as controls. Each lane represents data obtained from a separate mouse. (A)
ion in the brains of infected mice at 11 dpi. (B) Kinetics of chemokine gene
te infection from three separate infection experiments analyzed as in panel A.
L32 housekeeping gene. Mean values and standard deviations are presented for
roups was determined using ANOVAwith subsequent Newman–Keuls analysis
Fig. 8. Brain cellular inflammatory responses following intranasal infection. Hematoxylin and eosin-stained sections of brains of mock-infected mice and mice infected
with 105 PFU of wt MAV-1 or pmE109 at 11 and 15 dpi. Arrows indicate blood vessels within each image. Scale bar, 200 μm.
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change over time in the brains of mock-infected mice (Fig. 9A).
There was little difference in expression levels of any of the
genes measured in brains of wt virus- or pmE109-infected mice
compared to mock-infected mice at 7 dpi. At 11 dpi, we
detected increases in the expression of genes encoding CD4,
CD8α, CD19 and F4/80 in the brains of mice infected with wt
virus compared to mock-infected mice, but not in the brains of
pmE109-infected mice (Fig. 9A). Expression of all four genes
peaked at 15 dpi in the brains of wt virus-infected mice, and at
22 dpi they remained elevated over levels detected in mock-Fig. 9. Characterization of brain cellular inflammatory responses. Chemokine gene e
MAV-1 or pmE109. Animals mock-infected with conditioned media were included as
measured by RPA. Quantified PhosphorImager data are presented as a percentage of L
and 7 mice per group at each time point and include analysis of one infection experim
15 dpi. Statistical significance between groups was determined using ANOVAwith s
**P<0.01 and ***P<0.001 compared to mock-infected mice; †P<0.05, ††P<0.01
used to detect percentages of specific leukocyte subtypes in cell suspensions generat
pmE109 at 15 dpi. Mean values and standard deviations are presented for 4 mice per g
determined using ANOVAwith subsequent Newman–Keuls analysis between pairsinfected mice (Fig. 9A). Expression levels of these same genes
were greater in the brains of pmE109-infected mice than in
mock-infected mice at 15 and 22 dpi, but these levels remained
below those measured in the brains of wt virus-infected mice
(Fig. 9A).
We used flow cytometry to verify the phenotype of the
inflammatory cells present in the brains of infected mice at
15 dpi. Single-cell suspensions of brain homogenates were
stained with monoclonal antibodies to detect CD4 and CD8,
CD19, F4/80 and Ly-6 (neutrophils). The percentage of CD8-
positive cells was greater in brains of mice infected with wtxpression was measured in the brains of mice infected i.n. with 105 PFU of wt
controls. (A) Expression of genes encoding leukocyte cell surface markers was
32 expression. Mean values and standard deviations are presented for between 4
ent per time point at 7, 11 and 22 dpi and two separate infection experiments at
ubsequent Newman–Keuls analysis between pairs where appropriate (*P<0.05,
and †††P<0.001 compared to pmE109-infected mice). (B) Flow cytometry was
ed from mock-infected mice or mice infected i.n. with 105 PFU of wt MAV-1 or
roup. Where not seen, error bars are too small to be distinguished. P values were
where appropriate.
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9B). Likewise, the percentage of CD4-positive cells was greater
in brains of mice infected with wt virus or pmE109, although
the difference between mock-infected and wt virus-infected
mice was not statistically significant (Fig. 9B). The percentage
of Ly-6-positive cells was also greater in the brains of mice
infected with wt virus or pmE109 (Fig. 9B). Interestingly, the
percentage of CD19-positive cells was decreased in brains of
mice infected with wt virus or pmE109 compared to mock-
infected mice (Fig. 9B). F4/80-positive cells were not detected
by flow cytometry in the brains of any mice at 15 dpi (data not
shown).
Discussion
Acute adenovirus respiratory infection is associated with a
wide range of clinical presentations and can be a cause of
substantial morbidity and mortality (Horwitz, 2001). In
addition, adenovirus infection may contribute to the pathogen-
esis of some chronic lung diseases (Hogg, 2001). MAV-1
provides a model to study the pathogenesis of respiratory
infection by an adenovirus in its natural host. In this report, we
examined the role of the MAV-1 E1A gene product in
inflammatory responses to acute MAV-1 infection. We found
that i.n. inoculation of C57BL/6 mice with an E1A-null mutant
MAV-1 resulted in less chemokine induction and cellular
inflammation in the lungs than did inoculation with wt MAV-1.
CNS infection occurs following i.n. inoculation with wt virus
(Kajon et al., 1998), and we showed for the first time that CNS
infection also occurs following i.n. inoculation with an E1A-
null mutant virus (Fig. 6). Chemokine gene expression was
induced in the brains of mice infected with either wt or mutant
virus, but the magnitude of this response was lower in brains of
mice infected with the same dose of mutant virus.
Cellular immune responses are critical for the control of
respiratory viral infections. Lung chemokine responses have
been described following respiratory challenge with a variety of
viruses including respiratory syncytial virus (RSV), influenza
virus, murine gammaherpesvirus 68 (MHV-68) and MAV-1
(Bonville et al., 1999; Domachowske et al., 2000; Miller et al.,
2004; Miyazato et al., 2000; Tripp et al., 2000; Wareing et al.,
2004; Weinberg et al., 2002, 2005). Impaired chemokine
function affects the pathogenesis of respiratory viral infection.
CCR5 −/− mice infected with influenza A display higher
mortality rates and more lung pathology than do wt controls,
while influenza-infected CCR2 −/− mice are protected from
early pathological effects of infection, potentially due to
impaired macrophage accumulation in the lungs of CCR2 −/−
mice (Dawson et al., 2000). CCR2 −/− mice infected with
MHV-68 have decreased macrophage accumulation, increased
necrosis and increased neutrophil accumulation compared to
BALB/c control mice (Cadillac et al., 2005).
In this report, we demonstrate a cellular response in the
lungs following infection with both wt and E1A-null MAV-1
(Fig. 2). As we previously reported for wt virus (Weinberg et
al., 2005), this appears to be a predominantly mononuclear
infiltrate for E1A-null virus. Chemokines serve as chemoat-tractants for a wide variety of cells involved in host
inflammatory responses. The chemokines that were most
highly upregulated in the lungs following infection with wt
MAV-1 included the CC chemokines RANTES, MCP-1 and
TCA-3 and the CXC chemokine IP-10 (Fig. 1A and B). This
was similar to patterns of chemokine upregulation observed
following i.n. infection with a number of other viruses
including RSV (Miller et al., 2004), influenza virus (Wareing
et al., 2004) and MHV-68 (Weinberg et al., 2002). The
combined effect of these chemokines would be to attract a
population of cells to the lungs including T lymphocytes, NK
cells, monocytes and dendritic cells (Luster, 1998), suggesting
roles for these cell types in the control of MAV-1 respiratory
infection.
RANTES, MCP-1, TCA-3 and IP-10 were also the
chemokines that were most highly upregulated in the brain
following infection with either wt or E1A-null virus (Figs. 7A
and B). The kinetics of chemokine upregulation in the brain
were delayed compared to chemokine upregulation in the lung,
reflecting the fact that viral gene expression and viral genome
were not detected until 11 dpi in the brain (Figs. 6A and B). T
lymphocyte responses contribute to the immunopathology
observed in the CNS following i.p. infection with wt MAV-1
but are also important for long-term survival of infected mice
(Moore et al., 2003). The pattern of chemokine upregulation in
the brain described in this report following i.n. inoculation
suggests that T lymphocytes and potentially monocytes and
macrophages contribute to host inflammatory responses to CNS
infection following i.n. inoculation. Consistent with this, the
histological data, flow cytometry data and RPA data indicated
that CD8 T cells and to a lesser extent CD4 T cells were
increased in the brains of mice infected with wt virus or
pmE109 (Figs. 8 and 9). F4/80 gene expression was upregulated
in the brains of infected mice, suggesting that there was also an
influx of macrophages. F4/80-positive cells were not detected in
the brains of mice using flow cytometry, potentially due to small
numbers of these cells or technical issues involving the specific
antibody used. The patterns of chemokine upregulation
correlated with the qualitative amount of cellular inflammation
seen in the brains of mice infected with wt virus or pmE109;
there was less inflammation in brains of pmE109-infected mice
but the types of cells present were similar to those with wt virus
infection.
Mice deficient in B cells demonstrate increased susceptibility
to MAV-1 infection (Moore et al., 2004). Consistent with a role
of B cells in the control of acute MAV-1 infection, we
demonstrated upregulation of CD19 gene expression in the
brains of wt virus- and pmE109-infected mice by RPA analysis
(Fig. 9A). However, the percentage of CD19-positive cells
measured by flow cytometry was decreased in the brains of
infected mice at 15 dpi (Fig. 9B). It is possible that this
difference was due to technical reasons, as the brains of mice
were not perfused to remove peripheral blood cells prior to
RNA extraction, whereas brains were perfused prior to
homogenization and staining for flow cytometry. Similar
discrepancies were not observed for CD4 and CD8, arguing
against this explanation. Alternatively, technical issues with the
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the sensitivity of flow cytometry in this particular experiment.
Interestingly, we also detected an increased percentage of
neutrophils in the brains of infected mice (Fig. 9C). We have
previously reported a neutrophilic response in bronchoalveolar
lavage fluid obtained at 7 dpi from the lungs of mice infected
with wt MAV-1 (Weinberg et al., 2005). In each case, it is
possible that neutrophils may be recruited to sites of virus-
induced inflammation by the increased levels of IP-10, and to a
lesser extent MIP-1α and MIP-2, detected in lung (Fig. 1 and
Weinberg et al., 2005) and brain (Fig. 7), or by other
chemokines not included in the riboprobe template set we
used. It is possible that neutrophils have direct antiviral activity,
but it is more plausible that they make indirect contributions to
the control of MAV-1 infection. This may be by promoting the
loss of blood brain barrier integrity (Zhou et al., 2003) or by
secreting proinflammatory cytokines (Scapini et al., 2000) in
order to attract other cells responsible for controlling viral
infection.
By 22 dpi, expression levels of most chemokines measured
in the brains of mice infected with wt or E1A-null virus fell to
levels close to those measured in mock-infected mice (Fig. 7B
and data not shown). However, at 22 dpi expression of
RANTES remained significantly elevated in brains of mice
infected with both viruses (Fig. 7B). Similar observations were
made in an experimental model of herpes simplex virus
encephalitis, in which levels of expression of RANTES, but
not other chemokines measured, remained elevated in brains of
infected mice up to 2 months post-infection (Sellner et al.,
2005). Persistent upregulation of RANTES was also observed at
45 dpi in the spinal cords of mice infected with Theiler's murine
encephalomyelitis virus (Ransohoff et al., 2002). In each case,
the investigators postulated that persistent inflammation could
be caused by persistence of virus in the CNS. In this report, we
demonstrate persistence of MAV-1 genome in the brain at 22 dpi
(Fig. 6B), suggesting that the presence of virus may serve as a
continued inflammatory stimulus that aids in the control of viral
infection, contributes to immunopathologic damage or both.
Future work using mice deficient in RANTES or in CCR1
or CCR5, receptors for RANTES, may yield further impor-
tant information regarding the role of RANTES in MAV-1
pathogenesis.
Following i.n. inoculation with the E1A-null mutant virus
pmE109, viral gene expression and viral load were lower in
the lungs than following inoculation with an equal dose of wt
MAV-1. Similar differences between the viruses in viral gene
expression were seen in vitro following infection of LA-4
cells at an MOI of 0.1, but not at an MOI of 5. These data
suggest the possibility that lung infection is a condition that
resembles a low MOI infection in cell culture and that the
absence of MAV-1 E1A results in an in vivo replication
defect in the lung. In vivo, infection with E1A-null mutant
virus was associated with less pronounced cellular infiltrates
in the lung and less pronounced chemokine responses in
lungs and brain than infection with an equal dose of wt virus.
These blunted responses correlated with reduced levels of
viral replication in E1A-null mutant virus-infected mice.Decreased levels of virus in E1A-null mutant virus-infected
mice likely provided less of an inflammatory stimulus. This
explanation is supported by results in which equivalent viral
loads in lung infection with wt and mutant virus were
associated with equivalent levels of chemokine gene expres-
sion (Fig. 4).
Previous work from our laboratory demonstrated higher 50%
lethal doses for E1A-null mutant MAV-1 following i.p.
inoculation of Swiss outbred mice (Smith et al., 1998). Despite
its decreased virulence, the E1A-null mutant virus was found in
the same organs and in the same cell types as wt virus following
i.p. inoculation with 105 PFU of virus. The present study
suggests that the decreased virulence of an E1A-null mutant
virus does not depend on the route of inoculation. In addition,
our results show that dissemination of MAV-1 to the CNS
following acute respiratory infection does not depend on the
presence of E1A.
While lower levels of viral gene expression and lower viral
loads following infection with the E1A-null mutant pmE109
were most likely due to a replication defect, it is also possible
that the absence of MAV-1 E1A in mice infected with pmE109
allowed more effective clearance of the virus by host immune
responses. Many viruses, including the adenoviruses, have
evolved mechanisms to counteract host IFN responses to viral
infection. Although human adenovirus infection has been
shown to induce the transcription of a variety of interferon-
stimulated genes (ISG), both human adenovirus E1A (Reich et
al., 1988) and MAV-1 E1A (Kajon and Spindler, 2000) suppress
ISG transcription. Human adenovirus E1A inhibits IFN-α/β
and IFN-γ signaling by reducing levels of p48 and the signal
transducer and activator of transcription 1 (STAT1), two
members of the IFN-α/β-induced transcription complex
interferon-stimulated gene (ISG) factor 3 (ISGF3) (Ackrill et
al., 1991; Gutch and Reich, 1991; Kalvakolanu et al., 1991;
Leonard and Sen, 1996), and by inhibiting binding of ISGF3 to
IFN-stimulated response elements (Gutch and Reich, 1991).
The E1A-null mutant pmE109 is sensitive to the inhibitory
effects of IFN-α/β and IFN-γ in vitro, whereas wt MAV-1 is not
(Kajon and Spindler, 2000). ISG expression is decreased in the
presence of MAV-1 E1A following treatment with IFN-α/β, but
less so following IFN-γ treatment (Kajon and Spindler, 2000).
We did not detect differing levels of IFN-γ protein or mRNA in
the lungs of mock-infected mice or mice infected with wt MAV-
1 or pmE109 (data not shown). However, it is possible that, in
the absence of MAV-1 E1A, IFN-mediated responses resulted in
more effective clearance of virus and therefore subsequent
decreased chemokine responses in the lungs and brain due to
decreased viral replication.
Adenovirus E1A may affect chemokine responses to acute
infection in a variety of ways. Signaling pathways involving
NF-κB and AP-1 contribute to transcriptional control of a
variety of chemokine genes (Kaufmann et al., 2001; Roebuck et
al., 1999; Shin et al., 1994; Wickremasinghe et al., 2004).
Activation of NF-κB (Schmitz et al., 1996) and AP-1
(Kleinberger and Shenk, 1993; Muller et al., 1989) by E1A
may thereby enhance transcription of chemokine genes in
infected cells. IFN-α and IFN-γ enhance chemokine responses
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rhinovirus infection (Konno et al., 2002), respectively. Through
its inhibitory effects on IFN signaling, E1A may instead lead to
diminished chemokine responses in infected cells. These
possibilities are not mutually exclusive, and the ultimate effect
on chemokine production likely depends on contributions of
other host and viral factors.
Clinical and experimental animal data have provided the
basis for postulating that the human adenovirus E1A protein in
the setting of persistent rather than acute infection is responsible
for immunomodulatory effects contributing to chronic lung
diseases such as asthma and chronic obstructive pulmonary
disease (reviewed in Hogg, 2001). The majority (94%) of
children with asthma who showed an unfavorable response to
corticosteroid therapy had detectable adenovirus protein in
bronchoalveolar lavage fluid (BALF); 75% of a subset of these
patients available for study up to 1 year later had persistent
adenovirus antigen in BALF (Macek et al., 1994). Human
adenovirus infection of guinea pigs decreased steroid respon-
siveness in a model of allergic airways disease utilizing
ovalbumin (OVA) sensitization (Yamada et al., 2000). Adeno-
viral DNA is found in respiratory epithelial cells in patients with
COPD (Elliott et al., 1995; Matsuse et al., 1992), and cigarette
smoke-induced inflammation is amplified in the lungs of guinea
pigs infected with adenovirus (Vitalis et al., 1998). In vitro
studies support the hypothesis that human adenovirus E1A
modulates inflammatory responses to subsequent stimuli. For
instance, IL-8 is induced by lipopolysaccharide (LPS) exposure
to a greater degree in pulmonary epithelial cells transfected with
E1A than in E1A-negative cells (Higashimoto et al., 2002;
Keicho et al., 1997). Low levels of expression of MAV-1 E1A
can be detected by real-time PCR in the lungs of intranasally
infected mice at least until 44 dpi (data not shown). It is possible
that low-level persistence of MAV-1 E1A may amplify
inflammatory responses to subsequent stimuli in a manner
similar to that suggested for human adenovirus E1A.
Adenovirus vectors are involved in ongoing efforts to
develop safe and effective means to deliver genes to target cells
for both long-term genetic reconstitution in monogenic
disorders and transient gene delivery as primary or adjunctive
therapy for illnesses such as cancer. This work typically
involves the use of a replication-deficient adenovirus vector,
usually containing a deletion of the E1 coding region or
conditionally replicating adenovirus vectors characterized by
tumor-selective replication (reviewed in Young et al., 2006). For
example, replication-deficient adenovirus vector delivery of the
p53 tumor suppressor gene has been approved in China as a
treatment for head and neck cancers (Peng, 2005). Adenovirus
vector development has run into difficulties resulting from
widespread vector dissemination due to the broad tissue
distribution of cellular receptors for human adenoviruses
(Mizuguchi and Hayakawa, 2004). Inflammatory responses
elicited by the viral vectors are also thought to limit the
expression of delivered genes (Liu and Muruve, 2003). To
overcome these limitations, animal adenoviruses are being
developed for human gene therapy (reviewed in Bangari and
Mittal, 2006). Adenovirus vectors used for gene delivery andgene therapy are most often deleted of the E1 coding region to
render them replication deficient. Our findings suggest that an
MAV-1-based E1A-deleted vector may remain capable of
disseminating throughout the host, potentially producing
unanticipated effects in the host. Thus, even in the absence of
E1A, tissue distribution and inflammatory responses will
remain important considerations as adenoviruses are developed
for gene delivery applications.
Materials and methods
Viruses and cell lines
Wild type MAV-1 was grown and passaged in NIH 3T6
fibroblasts, and titers of viral stocks were determined by plaque
assay on 3T6 cells as previously described (Cauthen and
Spindler, 1999). In the MAV-1 strain pmE109, the E1A
translation initiator codon is mutated to TTG, resulting in the
absence of detectable E1A protein (Smith et al., 1996). pmE109
was grown and titrated on the E1A-complementing 37.1 cell
line as previously described (Smith et al., 1996). MH-S cells
(ATCC CRL-2019) were maintained in RPMI 1640 medium
(Gibco-BRL) supplemented with 10% calf serum (Gibco-BRL),
2 mM L-glutamine and penicillin–streptomycin (Gibco-BRL).
LA-4 cells (ATCC CCL-196) were maintained in Dulbecco's
modified Eagle medium (DMEM, Gibco-BRL) supplemented
with 10% fetal bovine serum (Gibco-BRL), 2 mM L-glutamine
and penicillin–streptomycin (Gibco-BRL).
In vitro infections
MH-S or LA-4 cells were seeded at 106 cells/well in 6-well
plates and incubated overnight at 37 °C. The following day,
the media was removed and cell monolayers were incubated at
37 °C for 60 min with wt MAV-1 or pmE109 at a multiplicity
of infection (MOI) of 0.1 or 5 PFU/cell in a total volume of
1 ml/well. Conditioned media were added to virus dilutions so
that the total amount of virus stock plus conditioned media
was equal across all conditions. An equivalent volume of
conditioned media in 1 ml fresh media was used for mock-
infected controls. Media were added to wells to bring the total
volume to 5 ml/well and the cells were incubated at 37 °C.
At the indicated time points, media were aspirated from the
wells and RNA was isolated from cells using 1 ml/well
TRIzol Reagent (Gibco-BRL) according to the manufacturer's
instructions.
Mouse infections
Four- to six-week-old male C57BL/6 mice were purchased
from Harlan and maintained in microisolator cages. Under light
isoflurane anesthesia, mice were inoculated i.n. with 105 PFU in
20 μl sterile phosphate-buffered saline (PBS). Control mice
were inoculated i.n. with conditioned media at an equivalent
dilution in PBS. In a separate experiment, mice were inoculated
with 104 PFU or 105 PFU MAV-1 or 105 PFU pmE109 brought
to 40 μl total volume with conditioned media. Mice were
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snap frozen in a dry ice and ethanol bath and stored at −20 °C
until processed further. All animal work complied with all
relevant federal and institutional policies.
Histology
In a subset of mice, lungs and brain were harvested and fixed
in 10% formalin. Prior to fixation, lungs were gently inflated
with PBS via the trachea to maintain lung architecture. After
fixation, organs were embedded in paraffin, and 5 μm sections
were cut for histopathology and immunohistochemistry. Sec-
tions were stained with hematoxylin and eosin to evaluate
cellular infiltrates.
Isolation of RNA and DNA from organs
The left lung was homogenized with sterile glass beads and
1 ml TRIzol Reagent (Gibco-BRL) using a Mini Beadbeater
(Biospec Products). The homogenates were incubated at room
temperature for 10 min, and then 200 μl of chloroform was
added to each sample. Following a 3-minute incubation at room
temperature, the tubes were centrifuged at 12,000×g for 15 min
at 4 °C. The aqueous phase was transferred to a new
microcentrifuge tube, and total RNA was precipitated with
isopropanol. DNA was extracted from approximately one-third
of the right lung using the DNeasy Tissue Kit (Qiagen Inc.)
according to the manufacturer's protocol.
Ribonuclease protection assays
Total RNA was analyzed by RPA to measure viral and
chemokine gene expression as previously described (Rochford
et al., 2001; Weinberg et al., 2005). Expression of murine
chemokines was measured using the mCK-5c riboprobe
template (PharMingen), and expression of cell surface markers
was measured using the mCD-1 riboprobe template (PharMin-
gen). A genomic MAV-1 hexon probe was prepared from
plasmid pHEX as described (Fang et al., 2004). The full-length
hexon template measured 395 nt, and the size of the protected
fragment was 337 nt. The template for the internal L32 (Hobbs et
al., 1993) control was previously described. Linearized MAV-1
hexon and L32 templates were combined in equimolar
concentrations for use in riboprobe syntheses driven by T7
bacteriophage RNA polymerase. All syntheses used [α-32P]
UTP (Amersham) as the labeling nucleotide. Probe bands were
visualized by autoradiography and were quantified where
indicated using a Storm or Typhoon PhosphorImager (GE
Healthcare) and ImageQuant software (GE Healthcare). Probe
bands remained within the linear range of detection of these
PhosphorImager systems.
Measurement of chemokine protein
Protein levels of the murine chemokine RANTES were
measured in supernatants from organ homogenates obtained as
described above. Specific chemokines were quantified using astandard method of sandwich ELISA as previously described
(Hogaboam et al., 1998; Walley et al., 1997). In brief, microtiter
plates were coated with the appropriate chemokine capture
antibody. Samples were added to wells for 1 h at 37 °C.
Recombinant murine chemokine standard curves were used to
calculate the chemokine concentrations. Detection and
processing were performed with the appropriate biotinylated
polyclonal rabbit anti-cytokine antibody (3.5 μg/ml), strepta-
vidin–peroxidase conjugate (Bio-Rad) and chromogen sub-
strate (Bio-Rad). Plates were read on an ELISA plate scanner
at 492 nm.
Measurement of viral load
Wild type MAV-1 and pmE109 viral loads were measured in
lung and brain using quantitative real-time PCR (qPCR).
Primers were designed to detect a 265-bp region of the MAV-1
hexon gene (GenBank NC_000942), found in both wt MAV-1
and pmE109, as follows: forward 5′-CACACCTTTCAGC-
GAGTTTCA-3′, reverse 5′-GCCGGGCCAGGGGTTCAA-3′.
DNA (100 ng per sample) was added to reactions containing
forward and reverse primers at 100 nM, iQ SYBR Green
Supermix (Bio-Rad), and water in a total volume of 25 μl per
reaction. Each sample was run in triplicate. Real-time PCR
analysis was performed using an iCycler iQ Multi-Color Real-
Time PCR Detection System (Bio-Rad), with an initial 5-minute
denaturation at 95 °C followed by 40 cycles of 10 s at 95 °C and
30 s at 60 °C. Melt curve analysis was performed after each
analysis to confirm the specificity of each amplification.
Standard curves generated using known amounts of plasmid
containing the MAV-1 hexon gene were used to convert cycle
threshold values for experimental samples to copy numbers of
hexon DNA. The lower limit of detection of this assay was
consistently below 1 copy per 100 ng DNA.
Flow cytometry
Brains were harvested from a subset of mice in order to
phenotype inflammatory cells by flow cytometry. Mice were
euthanized and perfused with PBS; some residual pink color
indicative of red blood cells was observed in some brains until
after the Percoll gradient (below). Brains were harvested and
kept in 5 ml ice-cold PBS. Single-cell suspensions were created
from each brain using a dounce homogenizer. To separate
leukocytes from cell debris, 2.5 ml Percoll (Sigma) was added
to the 5 ml of brain homogenate to create a 33% Percoll
solution. This solution was underlaid with 1 ml of 90% Percoll
in DMEM. Leukocytes were isolated following a 30-minute
centrifugation at 1200×g, washed and resuspended in PBS. Fc
receptors were blocked with anti-CD16/32 (Fc block; BD
Pharmingen). Cell suspensions from individual brains were
aliquoted into three equivalent volumes, pelleted and stained
with monoclonal antibodies specific for CD8, CD4, CD19 and
Ly-6G/C (all from BD Pharmingen) and F4/80 (CALTAG
Laboratories). After staining, cells were analyzed on a FACScan
flow cytometer (BD Biosciences) using Cell-Quest software
(BD Biosciences).
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Results are reported as the mean±standard deviation of each
group at each time point. Results were analyzed for statistical
significance using Microsoft Excel (Microsoft) and Prism 3 for
Macintosh (GraphPad Software Incorporated). Differences
between two groups were analyzed using an unpaired Student's
t test assuming unequal variance. Differences betweenmore than
two groups were analyzed using a one-way analysis of variance
(ANOVA) with subsequent Newman–Keuls multiple compar-
ison tests to analyze pairs of groups when indicated.
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